SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma
Clinical trial NCT04014101 · UNKNOWN
Trial details
- NCT number
- NCT04014101
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-01
- Primary completion
- 2019-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.